Physician profile
William Michael Jaffe
NPI 1083648158
$33,309.87
in general payments reported to CMS, 2019-2025
24 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,199 · 2020: $11K · 2021: $235 · 2022: $364 · 2023: $644 · 2024: $230 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $1,965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,500.00 |
| Food and Beverage | $1,964.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,689.21 | 2019-2025 | Watchman Access System, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $10,816.06 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,780.26 | 2019-2025 | Lifevest |
| Medtronic, INC. | $622.35 | 2021-2024 | Micra, Interstim |
| Medtronic Vascular, INC. | $232.33 | 2019-2020 | |
| Amgen INC. | $158.24 | 2019-2023 | Repatha |
| Anumana, INC. | $133.33 | 2025 | Ecg-Ai Lef |
| Astellas Pharma US INC | $132.85 | 2019 | |
| Zoll Medical Corporation | $101.60 | 2025 | Defibrillator |
| Novartis Pharmaceuticals Corporation | $95.09 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $87.97 | 2019-2025 | Camzyos |
| Philips North America LLC | $76.40 | 2022 | |
| Kestra Medical Technology Services, INC. | $57.97 | 2024-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $55.36 | 2019 | |
| Pfizer INC. | $46.96 | 2019-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $42.77 | 2023-2025 | |
| Abbott Laboratories | $41.99 | 2020 | |
| Janssen Pharmaceuticals, INC | $23.94 | 2023 | Xarelto |
| Irhythm Technologies, INC. | $23.64 | 2019 | |
| Lundbeck LLC | $23.62 | 2019 | |
| Cvrx, INC. | $22.57 | 2025 | Barostim Neo System |
| Kowa Pharmaceuticals America, INC. | $16.83 | 2019 | |
| Novo Nordisk INC | $14.64 | 2023 | Ozempic |
| Astrazeneca Pharmaceuticals Lp | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.